x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

business

All Episodes

20:06

Episode 87: Derek Lowe on China's new Alzheimer's...

The Readout Loud ·

2019/11/07

Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?

en

28:13

Episode 86: Drugs that don't work, wearables in the...

The Readout Loud ·

2019/10/31

When should a drug be pulled from shelves? How do you pronounce "HLTH?" And how does Ann Coulter decide what to tweet?

en

28:18

Episode 85: Every angle on Biogen's shocking...

The Readout Loud ·

2019/10/24

What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entire episode to Biogen's stunning announcement that aducanumab, its once-discarded treatment for Alzheimer's disease, is getting a second life.

en

26:13

Episode 84: CRISPR with Netflix filmmakers, Pharma's...

The Readout Loud ·

2019/10/17

Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?

en

23:46

Episode 83: How biotech VC works w/ health care...

The Readout Loud ·

2019/10/10

STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment. Then, we discuss how the synthetic biology industry is growing up and getting corporate. Finally, health care journalist Maggie Fox dials in to explain her deep dive on venture capital in biotech.

en

23:17

Episode 82: Drug shortages with Dr. Ben Davies,...

The Readout Loud ·

2019/10/03

Does impeachment have a pharma angle? Who's to blame for drug shortages? And why is Wall Street down on biotech?

en

26:01

Episode 81: Vaping upheaval, DNA test dynamics, & the...

The Readout Loud ·

2019/09/26

What do we talk about when we talk about "vape"? Are there limits to business of DNA testing? And how hard is it to get yourself CRISPR'd? STAT's Megan Thielking joins the gang to break down a major week of news in the world of vaping and STAT's Sharon Begley relates the story of a desperate patient seeking off-the-books genome editing and its implications for the future of medical research.

en

29:07

Episode 80: Unicorn growth spurts, Amgen's future, &...

The Readout Loud ·

2019/09/19

Who puts horns on unicorns? How do graying drug companies find green ideas? And what would mice tweet?

en

19:36

Episode 79: Pelosi's drug pricing plan, Moderna's...

The Readout Loud ·

2019/09/12

House Speaker Nancy Pelosi’s drug pricing plan is aggressive, but is it viable? Can Moderna turn cells into tiny drug-making factories? What’s it like to cure your own rare disease?

en

24:27

Episode 78: Pharma existentialism, mainstreaming...

The Readout Loud ·

2019/09/05

What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?

en

18:17

Episode 77: Purdue, J&J, and a week of big opioid...

The Readout Loud ·

2019/08/29

What does Dr. Richard Sackler sound like? When is $500 million a small amount of money? And what will come of the drug companies at the heart of the opioid crisis?

en

23:20

Episode 76: Sarepta keeps a secret, an online army...

The Readout Loud ·

2019/08/22

How should you talk to friends about rejection? Can Facebook actually improve the lives of children? And how's biotech doing in China?

en

29:38

Episode 75: The serious side of spit kits, how BiTEs...

The Readout Loud ·

2019/08/15

Is anything too weighty to be explained over the internet? Can a new spin on old technology outfox CAR-T? And does that controversial drug even work?

en

19:33

Episode 74: Novartis and the no good, very bad week

The Readout Loud ·

2019/08/08

Why did Novartis (NVS) keep its scandal to itself? Who knew what and when? And is there such thing as too much Peloton time?

en

23:51

Episode 73: Canadian pills, corporate jets, & racists...

The Readout Loud ·

2019/08/01

Will Canada run out of drugs? Should you ever read your partner's diary? And what does Pepe the Frog know about genomics?

en

26:33

Episode 72: Vertex's regime change, the return of...

The Readout Loud ·

2019/07/25

What makes an epidemic newsworthy? Can biotech succession succeed? And what's so novel about digital health?

en

25:37

Episode 71: Elon Musk's monkey cyborg, Gilead's...

The Readout Loud ·

2019/07/18

Can apps treat anxiety? Is Gilead Sciences back on track? And are we all just brains in a vat?

en

29:52

Episode 70: A whirlwind week in Washington, Sean...

The Readout Loud ·

2019/07/11

Is drug pricing too complex for the Trump administration? Would you recognize Tom Hanks at a party? And what does it mean when famous executives quit?

en

25:31

Episode 69: The future of AbbVieGan, the dogma of...

The Readout Loud ·

2019/06/27

Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?

en

26:49

Episode 68: A controversial desire drug, courtroom...

The Readout Loud ·

2019/06/20

Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all?

en

388 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...